|
GGA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.20029608053596E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.89189999514284E-08 |
| Normal-vs-Stage2 |
4.603600E-03 |
| Normal-vs-Stage3 |
5.247800E-02 |
| Normal-vs-Stage4 |
1.763990E-01 |
| Stage1-vs-Stage2 |
5.756400E-01 |
| Stage1-vs-Stage3 |
2.032200E-01 |
| Stage1-vs-Stage4 |
8.636600E-01 |
| Stage2-vs-Stage3 |
1.791990E-01 |
| Stage2-vs-Stage4 |
6.667400E-01 |
| Stage3-vs-Stage4 |
5.884600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.08109981972393E-10 |
| Normal-vs-AfricanAmerican |
2.628100E-04 |
| Normal-vs-Asian |
6.944000E-02 |
| Caucasian-vs-AfricanAmerican |
2.175200E-01 |
| Caucasian-vs-Asian |
9.880000E-01 |
| AfricanAmerican-vs-Asian |
6.403800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.86189960618799E-10 |
| Normal-vs-Female |
1.41119999996775E-06 |
| Male-vs-Female |
8.222400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.762500E-03 |
| Normal-vs-Extreme_Weight |
4.04909999995873E-06 |
| Normal-vs-Obese |
3.70299999999935E-05 |
| Normal-vs-Extreme_Obese |
5.624400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.405600E-01 |
| Normal_Weight-vs-Obese |
6.148000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.201000E-01 |
| Extreme_Weight-vs-Obese |
9.052200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.644000E-01 |
| Obese-vs-Extreme_Obese |
9.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.98900999999196E-05 |
| Normal-vs-Age(41-60Yrs) |
9.85710402190421E-11 |
| Normal-vs-Age(61-80Yrs) |
5.19269999998961E-07 |
| Normal-vs-Age(81-100Yrs) |
7.854000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.387600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.290300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.811800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.223600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.740100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.776200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71840319751482E-12 |
| Normal-VS-Type2 PRCC |
7.397700E-02 |
| Normal-VS-KIRP CIMP |
2.240200E-01 |
| Normal-VS-Unclassified PRCC |
1.153140E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.28749999994682E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.669600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.035600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.297800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.743700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.363450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.681370E-03 |
| Normal-vs-N1 |
1.737820E-02 |
| Normal-vs-N2 |
3.109400E-01 |
| N0-vs-N1 |
4.689000E-01 |
| N0-vs-N2 |
6.326200E-01 |
| N1-vs-N2 |
9.481600E-01 |
|
|
